In Medical Devices, Buy Now, Pay Later?
Executive SummaryIn the midst of a tremendous acquisition frenzy by large device companies, some small companies are staving off the inevitable by selling minority equity stakes to big companies. Small companies stay independent longer, while big companies get an early look and a lower acquisition cost down the road, if they still want it.
You may also be interested in...
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.